Celregen Therapeutics

This early-stage study tests a new treatment called CRG-002, made from special lab-grown cells that act like natural insulin-producing cells. It is for people with type 1 or pancreatic diabetes who have dangerous low blood sugar episodes. The goal is to see if these cells are saf…